I
GSK icon

IberiaBank’s GSK GSK Stock Holding History

IberiaBank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,394
Closed -$230K – 259
2019
Q1 		$230K Sell
4,394
-904
-17% -$45.2K 0.03% 224
2018
Q4 		$253K Sell
5,298
-2,752
-34% -$136K 0.03% 215
2018
Q3 		$404K Buy
+8,050
New +$409K 0.05% 204
2014
Q3 		– Sell
-4,621
Closed -$309K – 173
2014
Q2 		$309K Buy
+4,621
New +$313K 0.17% 114
2013
Q3 		– Sell
-3,490
Closed -$218K – 153
2013
Q2 		$218K Buy
+3,490
New +$222K 0.16% 128

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

IberiaBank's GSK Position: Q2 2019 in Review

IberiaBank sold out of GSK (GSK) in Q2 2019, closing a stake of 4,394 shares — an estimated $230K sold.

IberiaBank first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $404K in Q3 2018. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • IberiaBank reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • IberiaBank sold 4,394 GSK shares in Q2 2019, an estimated $230K.
  • IberiaBank first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • IberiaBank's GSK position peaked at $404K in Q3 2018.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on IberiaBank's 13F filing for Q2 2019, filed 29 Jul 2019.